{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:44:57Z","timestamp":1792464297219,"version":"4.5.0"},"reference-count":35,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,16]]},"DOI":"10.26633\/rpsp.2024.90","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:42:00Z","timestamp":1734349320000},"page":"1","source":"Crossref","is-referenced-by-count":11,"title":["Global challenges and solutions to achieving and sustaining measles and rubella elimination"],"prefix":"10.26633","volume":"48","author":[{"given":"Natasha S.","family":"Crowcroft","sequence":"first","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"},{"name":"crowcroftn@who.int"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Minta","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Antoni","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Lee","family":"Ho","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perea","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya Sekhar","family":"Bose","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Wallace","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Chang","family":"Blanc","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra S, Lambert B, et al. Progress Toward Measles Elimination \u2013 Worldwide, 2000\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72(46):1262\u20131268. https:\/\/doi.org\/10.15585\/mmwr.mm7246a3.","DOI":"10.15585\/mmwr.mm7246a3"},{"key":"ref2","unstructured":"World Health Organization. Feasibility Assessment of Measles and Rubella Eradication. Report to the Strategic Advisory Group of Experts. 8 October 2019. Geneva: WHO; 2019 [cited 21 January 2024]. Available from: https:\/\/terrance.who.int\/mediacentre\/data\/sage\/SAGE_Docs_Ppt_Oct2019\/4_session_measles_and_rubella_vaccines\/Oct2019_session4_feasibility_assessment_Measles-Rubella_eradication.pdf."},{"key":"ref3","unstructured":"World Health Organization. Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Geneva: WHO; 2020. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/ia2030."},{"key":"ref4","unstructured":"World Health Organization. Measles and Rubella Strategic Framework: 2021\u20132030. Geneva: WHO; 2020. Available from: https:\/\/iris.who.int\/handle\/10665\/339801."},{"key":"ref5","unstructured":"Pan American Health Organization. The Challenge of Maintaining the Elimination of Measles in the Americas, 2017-2018. Immunization Newsletter, v.40, n.3, Sep. 2018. Washington, D.C.: PAHO; 2018. Available from: https:\/\/iris.paho.org\/handle\/10665.2\/54261."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Vynnycky E, Knapp JK, Papadopoulos T, Cutts FT, Hachiya M, Miyano S, et al. Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019. Int J Infect Dis. 2023 Dec;137:149\u2013156. https:\/\/doi.org\/10.1016%2Fj.ijid.2023.09.003.","DOI":"10.1016\/j.ijid.2023.09.003"},{"key":"ref7","unstructured":"World Health Organization. Immunization dashboard. Geneva: WHO; 2024 [cited 15 July 2024]. Available from: https:\/\/immunizationdata.who.int\/."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sim SY, Watts E, Constenla D, Brenzel L, Patenaude BN. Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30. Health Aff (Millwood). 2020;39(8):1343\u20131353. https:\/\/doi.org\/10.1377\/hlthaff.2020.00103.","DOI":"10.1377\/hlthaff.2020.00103"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Carter A, Msemburi W, Sim SY, Gaythorpe KAM, Lambach P, Lindstrand A, et al. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030. Vaccine. 2024;42(Suppl 1):S28\u2013S37. https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.033.","DOI":"10.1016\/j.vaccine.2023.07.033"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420\u2013e428. https:\/\/doi.org\/10.1016\/s1473-3099(17)30307-9.","DOI":"10.1016\/S1473-3099(17)30307-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lessler J, Metcalf CJE. Balancing evidence and uncertainty when considering rubella vaccine introduction. PLoS One. 2013;8(7):e67639. https:\/\/doi.org\/10.1371\/journal.pone.0067639.","DOI":"10.1371\/journal.pone.0067639"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Keeling MJ, Grenfell BT. Disease extinction and community size: modeling the persistence of measles. Science. 1997;275(5296):65\u201367. https:\/\/doi.org\/10.1126\/science.275.5296.65.","DOI":"10.1126\/science.275.5296.65"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Metcalf CJE, Munayco CV, Chowell G, Grenfell BT, Bj\u00f8rnstad ON. Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru. J R Soc Interface. 2011;8(56):369\u2013376. https:\/\/doi.org\/10.1098\/rsif.2010.0320.","DOI":"10.1098\/rsif.2010.0320"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Durrheim DN, Crowcroft NS. The price of delaying measles eradication. Lancet Public Health. 2017;2(3):e130\u2013e131. https:\/\/doi.org\/10.1016\/s2468-2667(17)30026-9.","DOI":"10.1016\/S2468-2667(17)30026-9"},{"key":"ref15","unstructured":"Wellesley Institute. Health systems and health equity. Toronto: Wellesley Institute; [date unknown] [cited 21 January 2024]. Available from: https:\/\/www.wellesleyinstitute.com\/streams\/health-systems-and-health-equity."},{"key":"ref16","unstructured":"United Nations, Department of Economic and Social Affairs. Proportion of the target population covered by all vaccines included in their national programme. Sustainable Development Goal SDG3 indicator 3b 1.3. New York: United Nations; 2024 [cited 28 January 2024]. Available from: https:\/\/sdgs.un.org\/goals\/goal3."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Grant GB, Zimmerman L. Decreases in Congenital Rubella Syndrome Reflect Concerted Efforts Toward Rubella and Measles Elimination. Int J Infect Dis. 2023 Dec;137:162. https:\/\/doi.org\/10.1016\/j.ijid.2023.10.012.","DOI":"10.1016\/j.ijid.2023.10.012"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, et al. A world without measles. J Infect Dis. 2011 Jul;204(Suppl 1):S1\u2013S3. https:\/\/doi.org\/10.1093\/infdis\/jir111.","DOI":"10.1093\/infdis\/jir111"},{"key":"ref19","unstructured":"Rodney W. How Europe Underdeveloped Africa. London: Bogle-L\u2019Ouverture Publications; 1972."},{"key":"ref20","unstructured":"United Nations Educational, Scientific and Cultural Organization. Launch of the Report on \u201cHealing the Wounds of Trans-Atlantic Slave Trade and Slavery\u201d. 21 May 2021. Paris: UNESCO; 2021 [cited 21 January 2024]. Available from: https:\/\/www.unesco.org\/en\/articles\/launch-report-healing-wounds-trans-atlantic-slave-trade-and-slavery."},{"key":"ref21","unstructured":"Nunn N. Understanding the long-run effects of Africa\u2019s slave trades. Vox EU. 27 February 2017. [London]: Centre for Economic Policy Research; 2017 [cited 21 January 2024]. Available from: https:\/\/cepr.org\/voxeu\/columns\/understanding-long-run-effects-africas-slave-trades."},{"key":"ref22","unstructured":"Reuters. Africa seeks action plan on slavery reparations at Ghana conference. 15 November 2023 [cited 21 January 2024]. Available from: https:\/\/www.reuters.com\/world\/africa\/africa-seeks-action-plan-slavery-reparations-ghana-conference-2023-11-14\/."},{"key":"ref23","unstructured":"World Health Organization, United Nations Children\u2019s Fund, GAVI the Vaccine Alliance. The big catch-up: an essential immunization recovery plan for 2023 and beyond. Geneva: WHO; 2023. Available from: https:\/\/iris.who.int\/handle\/10665\/371801."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Truelove SA, Graham M, Moss WJ, Metcalf CJE, Ferrari MJ, Lessler J. Characterizing the impact of spatial clustering of susceptibility for measles elimination. Vaccine. 2019;37(5):732\u2013741. https:\/\/doi.org\/10.1016%2Fj.vaccine.2018.12.012.","DOI":"10.1016\/j.vaccine.2018.12.012"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Deer B. How the case against the MMR vaccine was fixed. BMJ. 2011 Jan 5;342:c5347. https:\/\/doi.org\/10.1136\/bmj.c5347.","DOI":"10.1136\/bmj.c5347"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"de Quadros CA, Oliv\u00e9 JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, et al. Measles elimination in the Americas. Evolving strategies. JAMA. 1996;275(3):224\u2013229. https:\/\/doi.org\/10.1001\/jama.1996.03530270064033.","DOI":"10.1001\/jama.275.3.224"},{"key":"ref27","unstructured":"World Health Organization. Rubella vaccines: WHO position paper \u2013 July 2020. Wkly Epidemiol Rec. 2020;95(27):301\u2013324. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-WER9527."},{"key":"ref28","unstructured":"O\u2019Connor, Patrick. Immunity profiles. Personal communication with: U.S. Centers for Disease Control and Prevention. 15 January 2024."},{"key":"ref29","unstructured":"World Health Organization. Measles Outbreaks Strategic Response Plan: 2021\u20132023. Geneva: WHO; 2021. Available from: https:\/\/iris.who.int\/handle\/10665\/340657."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Mulders MN, Rota PA, Icenogle JP, Brown KE, Takeda M, Rey GJ, et al. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65(17):438\u2013442. https:\/\/doi.org\/10.15585\/mmwr.mm6517a3.","DOI":"10.15585\/mmwr.mm6517a3"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Orenstein WA, Seib K. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination. Expert Rev Vaccines. 2016;15(7):791\u2013793. https:\/\/doi.org\/10.1586\/14760584.2016.1165614.","DOI":"10.1586\/14760584.2016.1165614"},{"key":"ref32","unstructured":"World Health Organization. Global Strategy on Comprehensive Vaccine-Preventable Disease Surveillance. Geneva: WHO; 2020. Available from: https:\/\/www.who.int\/publications\/m\/item\/global-strategy-for-comprehensive-vaccine-preventable-disease-(vpd)-surveillance."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Krudwig K, Knittel B, Karim A, Kanagat N, Prosser W, Phiri G, et al. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia. Vaccine. 2020;38(37):5905\u20135913. https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.012.","DOI":"10.1016\/j.vaccine.2020.07.012"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Adigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, et al. A measles and rubella vaccine microneedle patch in The Gambia: a phase 1\/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. Lancet. 2024;403(10439):1879\u20131892. https:\/\/doi.org\/10.1016\/s0140-6736(24)00532-4.","DOI":"10.1016\/S0140-6736(24)00532-4"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Brown DW, Warrener L, Scobie HM, Donadel M, Waku-Kouomou D, Mulders MN, et al. Rapid diagnostic tests to address challenges for global measles surveillance. Curr Opin Virol. 2020 Apr;41:77\u201384. https:\/\/doi.org\/10.1016\/j.coviro.2020.05.007.","DOI":"10.1016\/j.coviro.2020.05.007"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/62067\/v48e902024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:42:31Z","timestamp":1734349351000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/62067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":35,"alternative-id":["RPSP.2024.90"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2024.90","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}